{"id":330368,"date":"2026-10-28T12:45:32","date_gmt":"2026-10-28T07:15:32","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=330368"},"modified":"2026-10-28T12:45:32","modified_gmt":"2026-10-28T07:15:32","slug":"specialty-generics-and-branded-formulations-maker-domestic-brands-specialist-and-oncology-focused-drug-maker-stocks-roadmap-polaris-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/specialty-generics-and-branded-formulations-maker-domestic-brands-specialist-and-oncology-focused-drug-maker-stocks-roadmap-polaris-list\/","title":{"rendered":"3 Specialty Generics and Branded Formulations Maker, Domestic Brands Specialist and Oncology Focused Drug Maker Stocks With a Strong Future Roadmap: Alembic Pharmaceuticals, JB Chemicals and Pharmaceuticals and Natco Pharma"},"content":{"rendered":"

Alembic Pharmaceuticals, JB Chemicals and Pharmaceuticals and Natco Pharma: ROE of 11.9% to 17.1% and FY22 to FY26 revenue CAGR of 8.4% to 21.0%. Prices as of 27 Oct 2026.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

The three specialty and complex generics pharma stocks to watch are Alembic Pharmaceuticals, JB Chemicals and Pharmaceuticals and Natco Pharma. Their return on equity ranges from 11.9% to 17.1%, and their revenue compound annual growth from FY22 to FY26 ranges from 8.4% to 21.0%. JB Chemicals and Pharmaceuticals has the highest return on equity at 17.1%, while Natco Pharma has the fastest revenue growth at 21.0% a year. Prices are based on the 27 October 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n

Specialty and complex generics pharma stocks give investors a way to track businesses that sit close to everyday demand in India. Alembic Pharmaceuticals, JB Chemicals and Pharmaceuticals and Natco Pharma cover a specialty generics and branded formulations maker, a domestic brands specialist and an oncology focused drug maker.<\/p>\n

This list covers three specialty and complex generics pharma stocks with complete current figures: Alembic Pharmaceuticals, JB Chemicals and Pharmaceuticals and Natco Pharma. Every figure comes from the latest reported financials and the 27 October 2026 market close. Companies without complete current figures were left out.<\/p>\n

Click Here – Get Free Investment Predictions<\/a><\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n